Andrew Witty is a business executive well-known for his contributions to the Pharmaceutical and health sectors.

Glaxo Wellcome agreed to pay the University royalties on the worldwide sale of Ziagen, an AIDS-inhibiting drug, University President Mark Yudof announced Tuesday. About two-thirds of the royalty ...